COMMUNIQUÉS West-GlobeNewswire

Pathway Health Selected as Training and Implementation Partner for the Consonus Co-Pilot Application

09/10/2018 - 16:00

LAKE ELMO, Minn. and MILWAUKIE, Ore., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Pathway Health has been selected by Consonus Healthcare as its implementation, training and ongoing support services partner for its new app, [...]

Imprivata Extends Secure Medical Device Access to Howard Medical Storage Carts

09/10/2018 - 16:00

Technology integration will be on display at Cerner Health Conference LEXINGTON, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced a collaboration with Howard [...]

Lixte Biotechnology Files an IND with the FDA to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center

09/10/2018 - 15:45

EAST SETAUKET, NY , Oct. 09, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it has submitted an IND to the FDA to conduct a Phase 1b/2 trial of the safety and therapeutic [...]

Sharecare launches Sharecare Awards in association with The National Academy of Television Arts & Sciences, New York Chapter

09/10/2018 - 15:40

First-of-its-kind awards to honor excellence in health and wellness productions and programming; call for entries open through December 15 ATLANTA and NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital [...]

Portola Pharmaceuticals Supports 2018 World Thrombosis Day Campaign to Raise Awareness of Blood Clots as an Urgent and Growing Health Crisis

09/10/2018 - 15:05

Highlights Proactive Risk Assessment in Hospitals as Opportunity to Optimize Patient Outcomes SOUTH SAN FRANCISCO, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced [...]

Axovant Announces Data to be Presented at the Annual Congress of the European Society of Gene and Cell Therapy

09/10/2018 - 15:02

BASEL, Switzerland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON), a gene therapy company developing innovative treatments for debilitating neurologic and neuromuscular diseases, today announced [...]

Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing

09/10/2018 - 15:02

SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

Adventist Health Expands Program for Diabetic Retinopathy Screening

09/10/2018 - 15:00

Western U.S. Health Nonprofit Seizes Opportunity to Treat the Whole Patient by Integrating Advanced Screening Technology in 37 Hospitals and Clinics ROSEVILLE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Adventist Health [...]

Juneau Biosciences Presents New Genetic Discoveries in Endometriosis at ASRM Scientific Congress & Expo

09/10/2018 - 15:00

Presentation at premier infertility conference by Predictive Technology Group subsidiary awarded “Best in Clinical/Population Science Prize Paper” SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Predictive Technology [...]

APC Comments on Favorable Results in Initial Animal Studies

09/10/2018 - 15:00

VANCOUVER, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to report favorable results in initial animal [...]

Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes

09/10/2018 - 15:00

FREEHOLD, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO) , a leading global developer of cell-based technologies and therapeutics, announced today that Weill Cornell Medicine has selected [...]

Rafael Pharmaceuticals to Present at BIO Investor Forum 2018

09/10/2018 - 14:55

Newark, NJ, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that Sanjeev Luther, its President and Chief Executive [...]

CV Sciences, Inc.’s PlusCBD Oil™ featured on Oct. 3rd Episode of ‘The Dr. Oz Show’

09/10/2018 - 14:45

PlusCBD Oil™ Capsules featured as one of the industry-leading in efficacy and strength; Dr. Oz segment cites sales of CBD products expected to increase 700% over the next year LAS VEGAS, Oct. 09, 2018 (GLOBE NEWSWIRE [...]

Genocea Announces Upcoming Presentations at SITC 2018

09/10/2018 - 14:35

Posters showcase ability of ATLAS™ platform to identify neoantigens for inclusion in and exclusion from personalized immunotherapies CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ [...]

Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

09/10/2018 - 14:30

CALGARY, Alberta, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM) is pleased to announce that it has received all approvals from three new medical centers to be [...]

Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer

09/10/2018 - 14:30

Dr. Mark Murray, Arbutus President & Chief Executive Officer, to participate in a fireside chat at Chardan’s Genetic Medicines Conference at 2:45 pm ET today WARMINSTER, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- [...]

New Data from Adult ADHD Clinical Trial to be Presented at the 65th Annual AACAP Meeting

09/10/2018 - 14:30

Prof. Stephen Faraone, Ph.D. to present on October 25 in Seattle, Washington COLUMBIA, Md., Oct. 09, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc., and leader in developing specialty [...]

Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific Meeting

09/10/2018 - 14:30

LOS ANGELES, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]

CRUZANI Begins Product Development with Cannabis Derivatives for Edible and Infusion Markets

09/10/2018 - 14:30

ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI) is a global business development company focused on creating and acquiring franchise concepts, along with peripheral food-related businesses [...]